Search
Viking Therapeutics Inc
VKTXAdd to Watchlist
29.950USD
-1.580-5.01%
Close 09-15 16:00（ET）
3.49BMarket Cap
LossP/E TTM
Viking Therapeutics Inc (VKTX) Stock Price Target & Forecast
Analyst Rating
Based on 20 analysts giving stock ratings to Viking Therapeutics Inc in the past month.
Buy
7 Strong Buy
11 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
94.765USD+196.32%
VKTX Analyst Recommendation Trends
In the current month, VKTX has received 11 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. VKTX average Analyst price target in the last month is 94.765.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
7
7
7
7
7
7
7
7
11
11
11
11
10
10
10
10
2
2
2
2
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
20
20
20
19
19
18
18
VKTX Analyst Rating for Peer Comparison
Updated: Sep 15, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Financial Forecasting
Based on analysts' estimates, VKTX EPS is projected to reach -1.069 in FY2026Q3, following reported EPS of -1.101 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.89
-1.01
-1.25
-1.07
-1.08
Actual
-1.38
-1.37
-1.10
--
--
Surprise
-54.65%
-35.11%
+11.70%
--
--
FAQs
What is Viking Therapeutics Inc's price target?
Analysts forecast that Viking Therapeutics Inc's price target is USD 94.76, with the highest forecast at USD 125.00 and the lowest forecast at USD 35.00.
How have Viking Therapeutics IncVKTX's recent earnings per share performed?
The market expectation was USD -1.10, while Viking Therapeutics IncVKTX's earnings per share (EPS) for the previous quarter was USD -1.37. EPS for the next quarter is expected at USD -1.07.
What is the analyst rating for Viking Therapeutics Inc?
Based on the ratings of Viking Therapeutics Inc's stock from 20 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.